Drug Shortage Report for SODIUM PHOSPHATES INJECTION USP
Report ID | 93257 |
Drug Identification Number | 00896187 |
Brand name | SODIUM PHOSPHATES INJECTION USP |
Common or Proper name | SODIUM PHOSPHATES |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM PHOSPHATE DIBASIC SODIUM PHOSPHATE MONOBASIC |
Strength(s) | 268MG 276MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10 X 10ML |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-06-03 |
Estimated end date | 2019-12-02 |
Actual end date | 2019-10-31 |
Shortage status | Resolved |
Updated date | 2019-11-01 |
Company comments | Allocation at 75% of historical demand rate in place. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-11-01 | French | Compare |
v5 | 2019-11-01 | English | Compare |
v4 | 2019-09-10 | French | Compare |
v3 | 2019-09-10 | English | Compare |
v2 | 2019-09-09 | French | Compare |
v1 | 2019-09-09 | English | Compare |
Showing 1 to 6 of 6